Skip to main content

Advertisement

Log in

Coverage of seasonal malaria chemoprevention in children aged 3 to 59 months in Burkina Faso: a nationwide cross-sectional study

  • Original Article
  • Published:
Journal of Public Health Aims and scope Submit manuscript

Abstract

Aim

The objective of this study was to investigate seasonal malaria chemoprevention (SMC) coverage during the 2018 campaign and to identify factors associated with full coverage (receiving three doses of SMC four times during a campaign) of children aged 3 to 59 months.

Subject and methods

This was a cross-sectional study conducted in nine regions of Burkina Faso. In each region, we purposely selected districts based on the epidemiological profile and randomly selected villages within each district. The World Health Organization (WHO) Expanded Programme on Immunization (EPI) method was used in the household selection process. A generalized linear mixed model (GLMM) was used to account for the hierarchical structure of the design and to identify factors associated with full SMC coverage.

Results

Our results showed that community distributors (CDs) visited more than 98% of the selected households, and 95.9% of the children received three doses of SMC in the last round in October 2018. Furthermore, 84.8% of children were fully covered after having received all three doses of SMC during four campaigns by the end of 2018. The age of the children and the occupation of the respondent were factors significantly associated with complete SMC coverage.

Conclusion

Full coverage of SMC among children aged 3 to 59 months remained below the expected coverage by the Burkina Faso Ministry of Health. It will be up to the Ministry of Health to strengthen the system for monitoring SMC activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon request.

Code availability

Code for data cleaning and analysis is available from the corresponding author upon request.

Abbreviations

SMC :

Seasonal malaria chemoprevention

WHO :

World Health Organization

CBD :

Community-based distributor

CD :

Community distributor

CSPS :

Centre de Santé et de Promotion Social

GLMM :

Generalized linear mixed model

SP :

Sulfadoxine-pyrimethamine

AQ :

Amodiaquine

CBHW :

Community-based health workers

UNICEF :

United Nations Children's Fund

References

  • Ba EH, Pitt C, Dial Y, Faye SL, Cairns M, Faye E, Ndiaye M, Gomis JF, Faye B, Ndiaye JL, Sokhna C, Gaye O, Cisse B, Milligan P (2018) Implementation, coverage and equity of large-scale door-to-door delivery of Seasonal Malaria Chemoprevention (SMC) to children under 10 in Senegal. Sci Rep 8:5489. http://www.ncbi.nlm.nih.gov/pubmed/29615763

  • Bakai TA, Thomas A, Iwaz J, Atcha-Oubou T, Tchadjobo T, Khanafer N, Rabilloud M, Voirin N (2022) Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020. Malar J 21:400

    Article  PubMed  PubMed Central  Google Scholar 

  • Barry A, Issiaka D, Traore T, Mahamar A, Diarra B, Sagara I, Kone D, Doumbo OK, Duffy P, Fried M, Dicko A (2018) Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial. PLoS One 13:e0193296. https://doi.org/10.1371/journal.pone.0193296

  • Bicaba A, Serme L, Chetaille G, Kombate G, Bila A, Haddad S (2020) Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso. Malar J 19:118. https://doi.org/10.1186/s12936-020-03191-y

    Article  PubMed  PubMed Central  Google Scholar 

  • Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, Conway DJ, Jasseh M, Wiseman V, Milligan PJ, Greenwood B (2011) Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med 8:e1000409. http://www.ncbi.nlm.nih.gov/pubmed/21304921

  • Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, Diallo A, Ogboi JS, Moroso D, Van Hulle S, Eloike T, Snell P, Scott S, Merle C, Bojang K, Ouedraogo JB, Dicko A, Ndiaye JL, Milligan P (2021) Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries. PLoS Med 18:e1003727. https://doi.org/10.1371/journal.pmed.1003727

  • Chatio S, Ansah NA, Awuni DA, Oduro A, Ansah PO (2019) Community acceptability of Seasonal Malaria Chemoprevention of morbidity and mortality in young children: A qualitative study in the Upper West Region of Ghana. PLoS One 14:e0216486. http://www.ncbi.nlm.nih.gov/pubmed/31100072

  • Compaore R, Yameogo MWE, Millogo T, Tougri H, Kouanda S (2017) Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso. PLoS One 12:e0187460. https://doi.org/10.1371/journal.pone.0187460

  • Dane AV, Schneider BH (1998) Program integrity in primary and early secondary prevention: are implementation effects out of control? Clin Psychol Rev 18:23–45. https://doi.org/10.1016/S0272-7358(97)00043-3

    Article  CAS  PubMed  Google Scholar 

  • De Cola MA, Sawadogo B, Richardson S, Ibinaiye T, Traoré A, Compaoré CS, Oguoma C, Oresanya O, Tougri G, Rassi C, Roca-Feltrer A, Walker P, Okell LC (2022) Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria. BMJ Glob Health 7, e008021. https://gh.bmj.com/content/bmjgh/7/5/e008021.full.pdf

  • DHS (2017) Burkina Faso: Malaria indicator survey (MIS). URL https://dhsprogram.com/methodology/survey/survey-display-526.cfm. Accessed 06 April 2023

  • Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A (2017) Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. Malar J 16:325. http://www.ncbi.nlm.nih.gov/pubmed/28797263

  • Diawara SI, Konaté D, Kayentao K, Mihigo J, Shaffer JG, Sangare M, Ndabamenye P, Swedberg E, Garg LW, Gamache N, Keita B, Kamate B, Ndaruhutse P, Kone D, Sanogo V, Tounkara M, Diakité M, Doumbia S, Eckert E (2022) Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali. Parasite Epidemiol Control 18:e00258. https://doi.org/10.1016/j.parepi.2022.e00258

  • Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, Haddad S (2018) Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso. Am J Trop Med Hyg 98:524–533. https://doi.org/10.4269/ajtmh.17-0599

    Article  PubMed  Google Scholar 

  • Dusenbury L, Brannigan R, Falco M, Hansen WB (2003) A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res 18:237–56. https://doi-org.acces.bibl.ulaval.ca/https://doi.org/10.1093/her/18.2.237

  • Kirakoya-Samadoulougou F, De Brouwere V, Fokam AF, Ouédraogo M, Yé Y (2022) Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso. Malar J 21:143

    Article  PubMed  PubMed Central  Google Scholar 

  • Koko DC, Maazou A, Jackou H, Eddis C (2022) Analysis of attitudes and practices influencing adherence to seasonal malaria chemoprevention in children under 5 years of age in the Dosso Region of Niger. Malar J 21:375. https://doi.org/10.1186/s12936-022-04407-z

    Article  PubMed  PubMed Central  Google Scholar 

  • Konaté D, Diawara SI, Keita B, Sogoba N, Fayiçal M, Guindo A, Thiam S, Traoré SF, Shaffer JG, Doumbia S, Diakité M (2021) Effectiveness and Community Acceptance of Extending Seasonal Malaria Chemoprevention to Children 5 to 14 Years of Age in Dangassa, Mali. Am J Trop Med Hyg 106:648–654. https://doi.org/10.4269/ajtmh.21-0046

    Article  PubMed  PubMed Central  Google Scholar 

  • Konate D, Diawara SI, Sogoba N, Shaffer J, Keita B, Cisse A, Sanogo I, Dicko I, Guindo MDA, Balam S, Traore A, Kante S, Dembele A, Kasse F, Denou L, Diakite SAS, Traore K, M'Baye Thiam S, Sanogo V, Toure M, Diarra A, Agak GW, Doumbia S, Diakite M (2023) Effect of a fifth round of seasonal malaria chemoprevention in children aged 5–14 years in Dangassa, an area of long transmission in Mali. Parasite Epidemiol Control 20:e00283. https://doi.org/10.1016/j.parepi.2022.e00283

  • Manga IA, Tairou F, Seck A, Kouevidjin E, Sylla K, Sow D, Gueye AB, Ba M, Ndiaye M, Tine RCK, Gaye O, Faye B, Ndiaye JLA (2022) Effectiveness of seasonal malaria chemoprevention administered in a mass campaign in the Kedougou region of Senegal in 2016: a case-control study. Wellcome Open Res 7:216. https://doi.org/10.12688/wellcomeopenres.18057.3

  • Nadimpalli V HK (2012) Simplifying the analysis of complex survey data using the SAS survey analysis procedures. SAS Global Forum 2012;Paper 348–2012. https://support.sas.com/resources/papers/proceedings12/348-2012.pdf

  • NDiaye JL, Cisse B, Ba EH, Gomis JF, Ndour CT, Molez JF, Fall FB, Sokhna C, Faye B, Kouevijdin E, Niane FK, Cairns M, Trape JF, Rogier C, Gaye O, Greenwood BM, Milligan PJ (2016) Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial. PLoS One 11:e0162563. http://www.ncbi.nlm.nih.gov/pubmed/27764102

  • Ndiaye JA, Diallo I, Y ND, Kouevidjin E, Aw I, Tairou F, Ndoye T, Halleux CM, Manga I, Dieme MN, Ndiop M, Faye B, Olliaro P, Merle CS, Gaye O, Milligan P (2018) Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System. Pharmaceut Med 32:189–200. http://www.ncbi.nlm.nih.gov/pubmed/29983573

  • Okereke E, Smith H, Oguoma C, Oresanya O, Maxwell K, Anikwe C, Osuji LC, Ogazi O, Musa J, Rajab A, Shekarau E, Okoh F, Viganò E, Donovan L, Ward C, Baker K (2023) Optimizing the role of “lead mothers” in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria. Malar J 22:13. https://doi.org/10.1186/s12936-023-04447-z

    Article  PubMed  PubMed Central  Google Scholar 

  • OMS (2018) Lancement de la campagne 2018 de chimio prévention du paludisme saisonnier. URL https://www.afro.who.int/fr/news/lutte-contre-le-paludisme-au-burkina-faso-lancement-de-la-campagne-2018-de-chimio-prevention. Accessed 22 Jul 2022

  • Partnership A-S (2020) Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet 396:1829–1840. https://doi.org/10.1016/S0140-6736(20)32227-3

    Article  Google Scholar 

  • Reiner RC Jr, Hay SI (2022) The overlapping burden of the three leading causes of disability and death in sub-Saharan African children. Nat Commun 13:7457. https://doi.org/10.1038/s41467-022-34240-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sacko A, Sagara I, Berthé I, Diarra M, Cissoko M, Diarra SS, Coulibaly D, Sanogo M, Dicko A (2021) Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling Up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali. Int J Environ Res Public Health 18. https://doi.org/10.3390/ijerph18020840

  • Slaughter SE, Hill JN, Snelgrove-Clarke E (2015) What is the extent and quality of documentation and reporting of fidelity to implementation strategies: a scoping review. Implement Sci 10:129

    Article  PubMed  PubMed Central  Google Scholar 

  • Sokhna C, Cisse B, Ba el H, Milligan P, Hallett R, Sutherland C, Gaye O, Boulanger D, Simondon K, Simondon F, Targett G, Lines J, Greenwood B, Trape JF (2008) A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3:e1471. http://www.ncbi.nlm.nih.gov/pubmed/18213379

  • WHO (2008) Training for mid-level managers (MLM). Module 7: the EPI coverage survey. https://creativecommons.org/licenses/by-nc-sa/3.0/igo. Accessed 17 Aug 2020

  • WHO (2013) Seasonal Malaria Chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. https://apps.who.int/iris/handle/10665/85726. Accessed 14 May 2023

  • WHO (2015) World malaria report 2015. https://apps.who.int/iris/handle/10665/200018. Accessed 14 May 2023

  • WHO (2022) World malaria report 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022. Accessed 06 Apr 2023

Download references

Acknowledgements

We would like to thank our colleague for reviewing this English version of the manuscript. We would like also to thank the Ministry of the Health of Burkina Faso, The Programme National de Lutte contre le Paludisme (PNLP), and the mothers or guardians of children.

Funding

This study was supported by the World Bank and WHO.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Antarou Ly. The first draft of the manuscript was written by Antarou Ly, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Antarou Ly.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Burkina Faso Health Research Ethics Committee (no. 2019-3-031). As our target population was children under 5 years of age, consent was obtained from the children's mothers or guardians. Particular care was taken to respect the norms of confidentiality and nondisclosure of the participants' identities. The project staff signed a confidentiality and good ethical practice agreement.

Consent for publication

Not applicable.

Competing interests

All authors declare no competing interests associated with this manuscript.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ly, A., Lanou, H.B., Moyenga, L. et al. Coverage of seasonal malaria chemoprevention in children aged 3 to 59 months in Burkina Faso: a nationwide cross-sectional study. J Public Health (Berl.) (2023). https://doi.org/10.1007/s10389-023-02036-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10389-023-02036-7

Keywords

Navigation